Toho : Notice Regarding the Status of Acquisition of Company Stocks(123 KB)
October 02, 2023 at 09:09 pm
Share
Common stocks of the Company 2,500,000 shares (Maximum)
(3.87 % of the total number of outstanding shares (excluding treasury stock))
6 billion yen (Maximum)
from September 19, 2023 to March 31, 2024 Purchase at the Tokyo Stock Exchange
October 3, 2023
To whom it may concern:
Company Name:
TOHO HOLDINGS CO., LTD.
Corporate
Atsushi Udoh, Representative Director,
Representative:
CEO
(Prime Market of Tokyo Stock
Exchange Securities Code: 8129)
Contact:
Makoto Kawamura, Corporate Officer
and General Manager, Corporate
Communications and Investor
Relations Division
(TEL: 81-3-6838-2803)
Notice Regarding the Status of Acquisition of Company Stocks
(Acquisition of Company Stocks Pursuant to Articles of Incorporation
under Article 165, Paragraph 2 of the Companies Act of Japan)
TOHO HOLDINGS CO., LTD. is pleased to announce the status of acquisition of its stocks pursuant to the provision of Article 156 of the Companies Act of Japan, as applied mutatis mutandis pursuant to Article 165, Paragraph 3 of the Companies Act of Japan. An outline of the acquisition in progress is as described below.
1.
Type of stock acquired:
Common stock of the Company
2.
Total number of shares acquired:
0 shares
3.
Total cost of stock acquired:
0 yen
4.
Period of acquisition:
from September 19, 2023 to September 30, 2023(on the contract basis)
5.
Method of acquisition:
Purchase at the Tokyo Stock Exchange
(Reference)
1.Details of resolution concerning acquisition of company stocks, which was resolved at the Board of Directors' meeting held on September 15, 2023.
(1) Type of stock acquired:
(2) Total number of shares acquired:
(3) Total cost of stock acquired:
(4) Period of acquisition:
(5) Method of acquisition:
2.Total number of company stocks acquired pursuant to the above resolution of the Board of Directors.
(as of September 30, 2023)
(1)
Total number of shares acquired:
0 shares
(2)
Total cost of stock acquired:
0 yen
Attachments
Original Link
Original Document
Permalink
Disclaimer
Toho Holdings Co. Ltd. published this content on 03 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 October 2023 01:08:12 UTC.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.